Cargando…

Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review

Hypercalcemia is an ominous development in the course of malignancy associated with a mean survival of only several months. A majority of cases of hypercalcemia are related to humoral hypercalcemia of malignancy (HHM), where hypercalcemia is caused by increased levels of circulating parathyroid horm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheehan, Michael, Tanimu, Sabo, Tanimu, Yusuf, Engel, Jessica, Onitilo, Adedayo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154241/ https://www.ncbi.nlm.nih.gov/pubmed/32308599 http://dx.doi.org/10.1159/000506100

Ejemplares similares

Evaluating the adoption of voice recognition technology for real-time dictation in a rural healthcare system: A retrospective analysis of dragon medical one
por: Onitilo, Adedayo A., et al.
Publicado: (2023)

Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017)

Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years
por: Sheehan, Michael T, et al.
Publicado: (2021)

Hypercalcemia of Malignancy Complicated by Osteonecrosis of the Jaw Treated With Cinacalcet
por: Vasquez, Libia, et al.
Publicado: (2023)

Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
por: O’Callaghan, Sondra, et al.
Publicado: (2020)

Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017)

Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients
por: Sheehan, Michael T, et al.
Publicado: (2021)

Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report
por: Sanada, Junpei, et al.
Publicado: (2021)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma
por: Pulipati, Vishnu Priya, et al.
Publicado: (2019)

Cinacalcet corrects hypercalcemia in mice with an inactivating Gα(11) mutation
por: Howles, Sarah A., et al.
Publicado: (2017)

Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
por: Lim, Seungtaek, et al.
Publicado: (2013)

Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
por: Rasmussen, Anne Qvist, et al.
Publicado: (2011)

Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report
por: Faiq, Samya, et al.
Publicado: (2023)

Successful use of cinacalcet to treat parathyroid-related hypercalcemia in two pediatric patients
por: Mogas, E, et al.
Publicado: (2018)

Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review
por: Erdinc, Burak, et al.
Publicado: (2019)

Primary Epithelioid Sarcoma of the Scalp Complicated by Humoral Hypercalcemia of Malignancy
por: Tocco, Ilaria, et al.
Publicado: (2012)

Ectopic Intact PTH Secretion Causing Humoral Hypercalcemia of Malignancy
por: Rauf, Mohammad Talha, et al.
Publicado: (2021)

Hypercalcemia of Malignancy
por: Feldenzer, Kaitlin L., et al.
Publicado: (2018)

Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
por: Bech, Anneke, et al.
Publicado: (2012)

Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia
por: Oruc, A., et al.
Publicado: (2020)

The pattern and correlates of intimate partner violence among women in Kano, Nigeria
por: Tanimu, Tanko S., et al.
Publicado: (2016)

Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?
por: Onitilo, Adedayo A, et al.
Publicado: (2021)

Humoral hypercalcemia of pregnancy treated with bisphosphonates
por: Koren, Ronit, et al.
Publicado: (2018)

Combined Hepatocholangiocarcinoma Associated with Humoral Hypercalcemia of Malignancy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Colunga Biancatelli, Ruben Manuel Luciano, et al.
Publicado: (2019)

SAT-120 Humoral Hypercalcemia of Malignancy Caused by Squamous Cell Carcinoma of the Penis
por: Kanta, Romana, et al.
Publicado: (2020)

Development of a PTHrP Chemiluminescent Immunoassay to Assess Humoral Hypercalcemia of Malignancy
por: Ashrafzadeh-Kian, Susan Louise, et al.
Publicado: (2021)

Evaluation of Radiographic Pattern of Male Urethral Strictures in Nigeria: A Preliminary Report of a Proposed New Scoring System for Developing Countries
por: Ahidjo, Ahmed, et al.
Publicado: (2012)

OR30-5 Germline Ablation of G-Protein Subunit Alpha-11 in Mice Causes Hypercalcemia That Is Rectified by Treatment with Cinacalcet
por: Hannan, Fadil, et al.
Publicado: (2019)

Effects of Cinacalcet on Post-transplantation Hypercalcemia and Hyperparathyroidism in Adult Kidney Transplant Patients: A Single-Center Experience
por: Alpay, Nadir, et al.
Publicado: (2023)

A Case of Humoral Hypercalcemia of Malignancy Secondary to Hepatocellular Carcinoma with Fulminant Clinical Course
por: Castro-Camero, Pamela, et al.
Publicado: (2019)

Hypercalcemia of Malignancy
por: Malangone, Steve, et al.
Publicado: (2015)

Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss‐of‐Function Gα(11) Mutation
por: Gorvin, Caroline M, et al.
Publicado: (2017)

Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review
por: Nehru, Vijeyaluxmy Motilal, et al.
Publicado: (2017)

Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management
por: Meehan, Adrian D., et al.
Publicado: (2017)

SUN-504 Association of Primary Hyperparathyroidism and Humoral Hypercalcemia of Malignancy in a Patient with Metastatic Endocervical Adenocarcinoma
por: de la Portilla, Lori, et al.
Publicado: (2019)

THU534 Humoral Hypercalcemia Of Malignancy As Initial Presentation Of Hepatocellular Carcinoma And Monoclonal Gammopathy Of Undetermined Significance
por: Jovanovic, Filip, et al.
Publicado: (2023)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Taguchi optimization and modelling of stir casting process parameters on the percentage elongation of aluminium, pumice and carbonated coal composite
por: Ibrahim, Tanimu Kogi, et al.
Publicado: (2023)

Cinacalcet: the chemical parathyroidectomy?
por: Bellasi, Antonio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t0ujfc2f2gmo6bkkr4682a52cn